KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 91 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $432,000 | -30.0% | 22,537 | -78.1% | 0.02% | -40.0% |
| Q2 2019 | $617,000 | +634.5% | 102,937 | +613.9% | 0.04% | +600.0% |
| Q1 2019 | $84,000 | -79.6% | 14,418 | -67.1% | 0.01% | -80.8% |
| Q4 2018 | $411,000 | -30.7% | 43,818 | +25.6% | 0.03% | -3.7% |
| Q3 2018 | $593,000 | -67.4% | 34,874 | -67.4% | 0.03% | -63.5% |
| Q2 2018 | $1,819,000 | +818.7% | 107,119 | +623.0% | 0.07% | +825.0% |
| Q1 2018 | $198,000 | -37.1% | 14,816 | -55.0% | 0.01% | -42.9% |
| Q4 2017 | $315,000 | +8.2% | 32,916 | +24.0% | 0.01% | -6.7% |
| Q3 2017 | $291,000 | -51.4% | 26,552 | -60.5% | 0.02% | -44.4% |
| Q1 2016 | $599,000 | -41.2% | 67,170 | -12.7% | 0.03% | -43.8% |
| Q4 2015 | $1,019,000 | -28.9% | 76,950 | -43.5% | 0.05% | -9.4% |
| Q3 2015 | $1,433,000 | +184.9% | 136,109 | +727.1% | 0.05% | +211.8% |
| Q1 2015 | $503,000 | +6.8% | 16,457 | +7.8% | 0.02% | -32.0% |
| Q1 2014 | $471,000 | – | 15,270 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |